Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation. [electronic resource]
Producer: 20140909Description: 286-92 p. digitalISSN:- 1879-0887
- Carcinoma, Squamous Cell -- pathology
- Cell Line, Tumor
- DNA Repair
- Head and Neck Neoplasms -- pathology
- Humans
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds -- therapeutic use
- Radiation-Sensitizing Agents -- therapeutic use
- Sorafenib
- Squamous Cell Carcinoma of Head and Neck
- raf Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.